Ecosprin Plus Tablet 75 mg+75 mg is a combination antiplatelet therapy containing Clopidogrel 75 mg and Aspirin (Acetylsalicylic Acid) 75 mg. This combination is primarily used for the prevention of cardiovascular events such as heart attacks, strokes, and thrombotic complications in patients with coronary artery disease, peripheral artery disease, or a history of myocardial infarction.
The dual mechanism of action—Clopidogrel inhibiting ADP-mediated platelet aggregation and Aspirin blocking thromboxane A2 production—provides enhanced antiplatelet effects, making it more effective than either drug alone. Ecosprin Plus Tablet is prescribed for patients at high risk of clot formation, including those undergoing percutaneous coronary intervention (PCI) or stent placement.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Clopidogrel: 75 mg
Aspirin (Acetylsalicylic Acid): 75 mg
Ecosprin Plus Tablet 75 mg+75 mg is indicated for:
Prevention of recurrent cardiovascular events in patients with a history of myocardial infarction or ischemic stroke
Acute coronary syndrome (ACS) management, including unstable angina
Post-percutaneous coronary intervention (PCI) or stent placement to prevent stent thrombosis
Peripheral artery disease in patients at risk of thrombotic complications
Secondary prevention of atherothrombotic events in high-risk cardiovascular patients
Ecosprin Plus Tablet provides dual antiplatelet therapy (DAPT) through complementary mechanisms:
Clopidogrel:
Selectively and irreversibly inhibits the ADP receptor (P2Y12) on platelet surfaces.
Prevents ADP-mediated activation of platelets, reducing platelet aggregation.
Aspirin:
Irreversibly inhibits cyclooxygenase (COX-1) enzyme in platelets.
Reduces the synthesis of thromboxane A2, a potent promoter of platelet aggregation.
Together, Clopidogrel and Aspirin synergistically inhibit platelet aggregation, minimizing the risk of arterial clot formation and cardiovascular events.
Route: Oral
Dosage: As prescribed by a registered physician
The usual dose is one tablet once daily, preferably taken after meals to reduce gastrointestinal irritation. The tablet should be swallowed whole with water. Duration of therapy depends on the patient’s cardiovascular risk profile and the physician’s recommendations, especially in post-stent or acute coronary syndrome cases. Regular monitoring of blood pressure, kidney and liver function, and signs of bleeding is recommended.
Enhanced antiplatelet protection for high-risk cardiovascular patients
Reduces the risk of heart attack, stroke, and stent thrombosis
Combines two complementary mechanisms for synergistic efficacy
Convenient once-daily dosing improves adherence
Can be used in patients with coronary artery disease, peripheral artery disease, or post-PCI
Helps maintain vascular health and reduce thrombotic events
Use only under medical supervision
Contraindicated in patients with active bleeding, hemorrhagic stroke, peptic ulcer, or hypersensitivity to Clopidogrel or Aspirin
Increased risk of bleeding complications, including gastrointestinal bleeding
Monitor for side effects such as easy bruising, nosebleeds, black stools, or prolonged bleeding
Caution in patients taking anticoagulants, NSAIDs, or other antiplatelet agents
Seek immediate medical attention for severe or unexplained bleeding
Store below 30°C in a dry place
Protect from light and moisture
Keep out of reach of children
Dual Antiplatelet Therapy / Cardiovascular Protective Agent / Antithrombotic.
Login Or Registerto submit your questions to seller
No none asked to seller yet